May 12, 2026 — Johnson & Johnson has launched its Shockwave C2 Aero Coronary IVL catheter designed for improved ...
May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented ...
May 7, 2026 — AccurKardia, a provider of ECG-based diagnostics technology, recently announced that AK+ Guard has been ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
May 1, 2026 — Echo IQ recently announced it has deployed its AI-based decision support software for the assessment of ...
May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...
May 1, 2026 — Retia Medical recently announced the first public presentation of results from its non-invasive cardiac ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
May 6, 2026 — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions ...
The clinical case for combining CT and angiography in a single workflow has been settled. Purpose-built mobile imaging ...
May 4, 2026 — Johnson & Johnson recently announced new data from a novel U.S. pilot single-arm trial that evaluated the ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
May 4, 2026 — A new guideline from the American Society of Echocardiography (ASE) provides guidance for cardiovascular ...
Could a link between the heart, brain and immune system help reduce the occurrence of heart attacks and lessen the ...
April 29, 2026 — Agitated Solutions, Inc.(ASI) has received CE Mark approval in the European Union for its novel device ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Editor's Note: This is Part Two of a three-part series highlighting several of the presentations from the American ...
April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...
April 26, 2026 — New results from the multicenter catheter ablation versus anti-arrhythmic drugs for Ventricular ...
May 12, 2026
